MDT
96.72
-0.11%↓
A
139.6
-0.01%↓
VEEV
222.15
-0.07%↓
HQY
85.02
0%↓
NEOG
9.23
-0.11%↓
MDT
96.72
-0.11%↓
A
139.6
-0.01%↓
VEEV
222.15
-0.07%↓
HQY
85.02
0%↓
NEOG
9.23
-0.11%↓
MDT
96.72
-0.11%↓
A
139.6
-0.01%↓
VEEV
222.15
-0.07%↓
HQY
85.02
0%↓
NEOG
9.23
-0.11%↓
MDT
96.72
-0.11%↓
A
139.6
-0.01%↓
VEEV
222.15
-0.07%↓
HQY
85.02
0%↓
NEOG
9.23
-0.11%↓
MDT
96.72
-0.11%↓
A
139.6
-0.01%↓
VEEV
222.15
-0.07%↓
HQY
85.02
0%↓
NEOG
9.23
-0.11%↓
24h
Curent
Minim
3.7
Maxim
3.7
Recomandări | Cumpărare |
|---|---|
Prognoză pe 12 luni | +188.98% upside |
Următoarele câștiguri | 27 mar. 2026 |
|---|
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
15 dec. 2025, 16:30 UTC
Fortress Biotech Rises After FDA Accepts Application for Menkes Treatment
DJ
Citește
1 oct. 2025, 15:07 UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
Citește
10 mar. 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Citește
10 mar. 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Citește
10 mar. 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Citește
10 mar. 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Citește
10 mar. 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Citește
10 mar. 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Citește
10 mar. 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Citește
Modificare preț
By TipRanks
Prognoză pe 12 luni
Medie 10.75 USD 188.98%
Maxim 17 USD
Minim 4.5 USD
În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruFortress Biotech Inc - Dist în ultimele 3 luni.
By TipRanks
Cumpărare
2 ratings
2
Cumpărare
0
Păstrare
0
Vânzare
Ținând cont de 2 analiști care au acordat evaluări ale acțiunilor Fortress Biotech Inc - Dist în ultimele 3 luni.
$